GlassScriptPhysician profile
Spence D Harper
NPI 1851394803
$355.77
in general payments reported to CMS, 2019-2025
14 companies · $63.89 in 2025
The $63.89 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $21.15 · 2022: $44.98 · 2023: $71.31 · 2024: $50.33 · 2025: $63.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $68.52 | 2022-2024 | Nuzyra |
| Solventum Corporation | $41.86 | 2024-2025 | Promogran Prisma, Activ.A.C. |
| Stryker Corporation | $39.92 | 2019 | |
| Organogenesis INC. | $36.11 | 2023 | Puraply |
| Biocomposites INC | $23.67 | 2025 | Stimulan |
| Horizon Therapeutics Plc | $21.15 | 2021 | |
| Wright Medical Technology, INC. | $19.09 | 2019 | |
| Arthrosurface Incorporated | $19.05 | 2019 | |
| Treace Medical Concepts, INC. | $16.51 | 2022 | |
| Polynovo North America LLC | $16.20 | 2024 | Novosorb Btm |
| Medtronic, INC. | $15.97 | 2025 | Inceptiv |
| Melinta Therapeutics, LLC | $14.05 | 2019 | |
| Tactile Systems Technology INC | $12.00 | 2019 | |
| Smith+Nephew, INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spence Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.